Skip to content
Genetic Signatures
Investors
  • ASX | GSS $1.96
  • Careers
  • Distributors
    • Distributor Resources
  • USA
    • Australia
    • EU/Israel
Genetic Signatures Logo
  • Home
  • About Us
    • Company Background
    • Our Technology
    • Products & Applications
    • Intellectual Property
    • Our Board
    • Our Principal Advisors
    • Our Management Team
  • Our Products
      • Gastrointestinal Infections
            • Bacterial Pathogen detection
            • Parasite Pathogen Detection
            • Viral Pathogen Detection
      • Respiratory
            • Respiratory Pathogen Detection
            • Atypical Pathogen Detection
            • Coronavirus Detection
            • SARS-CoV-2 Detection
      • Sexual Health
            • Sexually Transmitted Infections
            • Reproductive Health
      • Anti-Microbial Resistance
            • ESBL Screening
            • CPO Screening
      • Meningitis
            • Viral Meningitis
            • Bacterial Meningitis
            • Fungal Meningitis
      • Tropical Disease
            • Flavivirus & Alphavirus Screening
      • Our New Product
      • Sample Processing Kits
      • General Purpose Reagents
      • All Products
  • Workflow
    • Genetic Signatures Automated Platforms
  • Publications
  • Resources
  • News
  • Contact Us

Home > News

Latest News

Latest News
October 16, 2020

Genetic Signatures (ASX: GSS) Annual Report 2020

Latest News
August 28, 2020

Watch ShareCafe’s Hidden Gems Webinar

Latest News
July 28, 2020

Genetic Signatures (ASX:GSS) Latest Investor Presentation released

Latest News
May 29, 2020

Genetic Signatures latest Investor Presentation

Latest News
May 1, 2020

Genetic Signatures’ CEO Dr. John Melki in Australia’s Sydney Morning Herald discussing how our technology is helping diagnose COVID-19 patients

Latest News
April 28, 2020

Genetic Signatures’ COVID-19 test highlighted in Australia’s recent Sydney Morning Herald

Latest News
April 1, 2020

Genetic Signatures CE-IVD approval now received for EasyScreen™ SARS-CoV-2 Detection Kit

Latest News
March 6, 2020

Genetic Signatures exhibiting at 6th Joint Conference of the DGHM & VAAM, 8-11 March, Germany

Latest News
December 2, 2019

Genetic Signatures exhibting at Klinik, Diagnostik und Therapie bei aktuellen Infektionserregern in Berlin (December 5 – 7 2019)

Latest News
November 20, 2019

Genetic Signatures visit from co-founder Chris Abbott

Latest News
November 18, 2019

Special advisor Sir Gregory Winter and co-founder of Genetic Signatures Chris Abbott visit

Latest News
November 6, 2019

Genetic Signatures exhibiting at the Association for Molecular Pathology 2019 Annual Meeting & Expo in Baltimore, November 7-9, 2019.

1 2 3 … 7 »
Genetic Signatures Logo

Genetic Signatures was founded in 2001 by the late Dr. Geoffrey Grigg. We are the developers of 3base™ technology which is the cornerstone of our EasyScreen™ Pathogen Detection Kits. Our proprietary technology provides hospital and pathology laboratories with the molecular tools to screen for a wide array of infectious pathogens in a rapid high-throughput environment.

Contact Us

Telephone:
+61 2 9870 7580

Email:
info@geneticsignatures.com

© 2021 Genetic Signatures. Terms & Conditions | Privacy Policy | Disclaimer

Our Address

Delivery Address
Genetic Signatures Ltd.
Heart Research Institute
7 Eliza Street Newtown,
NSW, 2042 Australia

Postal & Street Address
Genetic Signatures Ltd.
7 Eliza Street Newtown,
NSW, 2042 Australia

IMPORTANT Genetic Signatures’ global website caters to a range of users from many jurisdictions and could contain information regarding products not available in all countries. Products shown here may have received approval or clearance by a governing regulatory body for different purposes in different jurisdictions. Genetic Signatures does not take any responsibility for accessing such information which may not comply with any law, regulation, registration or usage in the jurisdiction where the reader resides.

Genetic Signatures is an
ISO 13485 certified company

bsi iso 13485 seal

Website design & development by

This website uses cookies to provide you with the best browsing experience.

Find out more or adjust your settings.

Genetic Signatures USA
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.